Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro.
D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000917:Antibody Formation; D000941:Antigens; D002175:Candida / Q000187:drug effects / Q000276:immunology; D002177:Candidiasis / Q000188:drug therapy / Q000276:immunology*; D002179:Candidiasis, Cutaneous / Q000276:immunology; D002180:Candidiasis, Oral / Q000276:immunology; D002181:Candidiasis, Vulvovaginal / Q000276:immunology; D002464:Cell Migration Inhibition; D002648:Child; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000032:analysis; D007165:Immunosuppression Therapy; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D012463:Saliva / Q000276:immunology; D012882:Skin Tests; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014374:Tuberculin Test
D000941:Antigens; D007136:Immunoglobulins; D037102:Lectins; D014316:Tritium; D000666:Amphotericin B; D013936:Thymidine